0000932440-16-000330.txt : 20160216
0000932440-16-000330.hdr.sgml : 20160215
20160216160451
ACCESSION NUMBER: 0000932440-16-000330
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20151231
FILED AS OF DATE: 20160216
DATE AS OF CHANGE: 20160216
EFFECTIVENESS DATE: 20160216
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ridgeback Capital Investments L.P.
CENTRAL INDEX KEY: 0001423994
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-12856
FILM NUMBER: 161427954
BUSINESS ADDRESS:
STREET 1: 75 NINTH AVENUE
STREET 2: 5TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10011
BUSINESS PHONE: 212-808-7729
MAIL ADDRESS:
STREET 1: 75 NINTH AVENUE
STREET 2: 5TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10011
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001423994
XXXXXXXX
12-31-2015
12-31-2015
false
Ridgeback Capital Investments L.P.
75 Ninth Avenue
5th Floor
New York
NY
10011
13F HOLDINGS REPORT
028-12856
Y
Ridgeback Capital Investments Ltd. is the general partner of Ridgeback Capital Investments L.P. Pursuant to an investment management agreement, Ridgeback Capital Management LP maintains investment and voting power with respect to the securities held or controlled by Ridgeback Capital Investments Ltd. Wayne Holman, an individual, controls Ridgeback Capital Management LP. Ridgeback Capital Management LP, Ridgeback Capital Investments Ltd. and Wayne Holman do not own any securities reported herein directly.
Ridgeback Capital Investments Ltd., as General Partner, by Bud Holman
Director
212-808-7729
/s/ Bud Holman
New York
NY
02-16-2016
2
4
23243
true
1
0001357610
028-12280
Ridgeback Capital Management LP
2
0001358916
028-12277
Ridgeback Capital Investments Ltd.
INFORMATION TABLE
2
infotable.xml
APPLIED GENETIC TECHNOLOGIES INC.
COM
03820J100
5019
246005
SH
SOLE
1,2
0
0
246005
CARA THERAPEUTICS, INC.
COM
140755109
10489
622140
SH
SOLE
1,2
0
0
622140
ONCOSEC MEDICAL INC.
COM
68234L207
3063
1292614
SH
SOLE
1,2
0
0
1292614
TRILLIUM THERAPEUTICS INC.
COM
89620X506
4672
370537
SH
SOLE
1,2
0
0
370537